|
Type |
Poster Presentation |
Area |
Medicinal Chemistry |
Room No. |
Event Hall |
Time |
4월 19일 (목요일) 11:00~12:30 |
Code |
MEDI.P-605 |
Subject |
Biological activity of secondary metabolites isolated from mushrooms |
Authors |
Seon-Jun Choi, Bong Geun Song, Pilju Choi1, Buyng Su Hwang2, Sang Il Jeon, Jungyeob Ham3,* Department of Chemistry, Gangneung-Wonju National University, Korea 1Department of Oriental Medicine, Gachon University Global Campus, Korea 2Industry Materialization Research Team, Nakdonggang National Institute of Biological Resou, Korea 3Natural Products Research, Korea Institute of Science and Technology, Korea |
Abstract |
Recently, treatment of cancer, hypertension, diabetes, arteriosclerosis, immune diseases is possible Human life has been prolonged. More than half of such therapeutic agents are produced on the basis of physiologically active compounds separated from natural products including microorganisms, plants and the like, and synthetic compounds derived from them. Among the natural products, there are about 8,000 species of mushrooms in the world, and have been widely used for edible use. In the early 1970 that began to study based on the scientific basis of mushrooms and most mushrooms are known to contain beta-glucan, a substance that enhances immune function. In Japan, as anti-cancer immunity such as Lentinan, Schizophyllan, Crestin, domestic is called Mesima-Ext. Up to now, about 100 kinds of compounds have been reported in mushrooms, and it has become apparent that there are compounds of various efficacies, and active research is under way.
In this study, we elucidated the structure of secondary metabolites of domestic mushrooms and confirmed the biologically active efficacy of these products.
|
E-mail |
117045@kist.re.kr |
|